Inhalers - Medical Devices Pipeline Assessment, 2019

Published : May-2019

No. of Pages : 357

order by fax Inquire before Buying request discount

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Inhalers Overview
3 Products under Development
3.1 Inhalers - Pipeline Products by Stage of Development
3.2 Inhalers - Pipeline Products by Segment
3.3 Inhalers - Pipeline Products by Territory
3.4 Inhalers - Pipeline Products by Regulatory Path
3.5 Inhalers - Pipeline Products by Estimated Approval Date
3.6 Inhalers - Ongoing Clinical Trials
4 Inhalers - Pipeline Products under Development by Companies
4.1 Inhalers Companies - Pipeline Products by Stage of Development
4.2 Inhalers - Pipeline Products by Stage of Development
5 Inhalers Companies and Product Overview
5.1 Acorda Therapeutics Inc Company Overview
5.2 Adamis Pharmaceuticals Corp Company Overview
5.3 Advent Pharmaceuticals Pty Ltd Company Overview
5.4 Aespira Ltd. Company Overview
5.5 AKELA Pharma Inc. (Inactive) Company Overview
5.6 Alexza Pharmaceuticals Inc Company Overview
5.7 Aradigm Corp Company Overview
5.8 AstraZeneca Plc Company Overview
5.9 Bayer AG Company Overview
5.10 Bellerophon Therapeutics Inc Company Overview
5.11 Bespak Europe Ltd Company Overview
5.12 Boehringer Ingelheim GmbH Company Overview
5.13 Circassia Pharmaceuticals Plc Company Overview
5.14 Drexel University Company Overview
5.15 Eli Lilly and Co Company Overview
5.16 FocusStart LLC Company Overview
5.17 GlaxoSmithKline Plc Company Overview
5.18 Lupin Pharmaceuticals Inc Company Overview
5.19 MannKind Corp Company Overview
5.20 Medihale Ltd (Inactive) Company Overview
5.21 Monash University Company Overview
5.22 Nektar Therapeutics Company Overview
5.23 North Carolina State University Company Overview
5.24 Novartis AG Company Overview
5.25 Ology Bioservices Inc Company Overview
5.26 OPKO Health Inc Company Overview
5.27 OtiTopic LLC Company Overview
5.28 Perrigo Co Plc Company Overview
5.29 Pharmaxis Ltd Company Overview
5.30 Pneuma Respiratory Inc Company Overview
5.31 Resolve Digital Health Inc Company Overview
5.32 Respira Therapeutics Inc Company Overview
5.33 Sandoz International GmbH Company Overview
5.34 Seng Vital International GmbH Company Overview
5.35 Senzer Ltd Company Overview
5.36 Sheffield Hallam University Company Overview
5.37 Softhale NV Company Overview
5.38 Spyryx Biosciences Inc Company Overview
5.39 Sun Pharma Advanced Research Company Ltd Company Overview
5.40 Syqe Medical Company Overview
5.41 Tetra Bio-Pharma Inc Company Overview
5.42 Teva Pharmaceutical Industries Ltd Company Overview
5.43 United Therapeutics Corp Company Overview
5.44 University of Kansas Company Overview
5.45 University of Sydney Company Overview
5.46 University of Texas Medical Branch at Galveston Company Overview
5.47 Uscom Ltd. Company Overview
5.48 Vectura Group Plc Company Overview
5.49 Verona Pharma Plc Company Overview
5.50 Virginia Commonwealth University Company Overview
6 Inhalers- Recent Developments
6.1 May 04, 2019: Vectura wins US GSK patent litigation and awarded $89.7Million in damages by trial jury
6.2 May 04, 2019: Vectura wins US GSK Patent Litigation and awarded $89.7Million in damages by Trial Jury
6.3 May 03, 2019: Novo Nordisk's operating profit increased by 14% in Danish kroner and by 8% at constant exchange rates (CER) in the first three months of 2019
6.4 May 02, 2019: Teva reports first quarter 2019 financial results
6.5 May 01, 2019: United Therapeutics reports first quarter 2019 financial results
6.6 May 01, 2019: GSK delivers sales of £7.7 billion +6% AER, +5% CER
6.7 Apr 30, 2019: Novo Nordisk to achieve target of 100% renewable power in production and launches new ambition aiming for zero environmental impact
6.8 Apr 30, 2019: Adherium: Appendix 4C- Quarterly cash flow report to 31 March 2019
6.9 Apr 25, 2019: 3M reports first-quarter 2019 results; company initiates restructuring
6.10 Apr 25, 2019: Orion Group Interim report January-March 2019
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

1.1 List of Tables
Table 1: Inhalers - Pipeline Products by Stage of Development
Table 2: Inhalers - Pipeline Products by Segment
Table 3: Inhalers - Pipeline Products by Territory
Table 4: Inhalers - Pipeline Products by Regulatory Path
Table 5: Inhalers - Pipeline Products by Estimated Approval Date
Table 6: Inhalers - Ongoing Clinical Trials
Table 7: Inhalers Companies - Pipeline Products by Stage of Development
Table 8: Inhalers - Pipeline Products by Stage of Development
Table 9: Acorda Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: INBRIJA - Product Status
Table 11: INBRIJA - Product Description
Table 12: PLUMIAZ Nasal Spray Device - Product Status
Table 13: PLUMIAZ Nasal Spray Device - Product Description
Table 14: Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Taper DPI - Product Status
Table 16: Taper DPI - Product Description
Table 17: Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 18: g60 Dry Powder Inhaler - Product Status
Table 19: g60 Dry Powder Inhaler - Product Description
Table 20: Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 21: resQhaler - Product Status
Table 22: resQhaler - Product Description
Table 23: AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Fentanyl TAIFUN Inhaler - Product Status
Table 25: Fentanyl TAIFUN Inhaler - Product Description
Table 26: Alexza Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Staccato System - Disposable Single Dose - Product Status
Table 28: Staccato System - Disposable Single Dose - Product Description
Table 29: Staccato System - Multiple Dose - Product Status
Table 30: Staccato System - Multiple Dose - Product Description
Table 31: Aradigm Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Aerx Pure Nicotine Inhaler - Product Status
Table 33: Aerx Pure Nicotine Inhaler - Product Description
Table 34: AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Duaklir Genuair Metered Dose Inhaler - Product Status
Table 36: Duaklir Genuair Metered Dose Inhaler - Product Description
Table 37: Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Ciprofloxacin Dry Powder Inhaler - Product Status
Table 39: Ciprofloxacin Dry Powder Inhaler - Product Description
Table 40: Bellerophon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Mark2 Device - Product Status
Table 42: Mark2 Device - Product Description
Table 43: Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 44: VAL020 Metered Dose Inhaler Valve - Product Status
Table 45: VAL020 Metered Dose Inhaler Valve - Product Description
Table 46: Boehringer Ingelheim GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Next Generation Respimat Inhaler - Product Status
Table 48: Next Generation Respimat Inhaler - Product Description
Table 49: Circassia Pharmaceuticals Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Tiotropium bromide DPI - Product Status
Table 51: Tiotropium bromide DPI - Product Description
Table 52: Drexel University Pipeline Products & Ongoing Clinical Trials Overview
Table 53: BREATHE Inhaler - Product Status
Table 54: BREATHE Inhaler - Product Description
Table 55: Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Nasal Glucagon Delivery System - Product Status
Table 57: Nasal Glucagon Delivery System - Product Description
Table 58: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Smart Inhaler - Product Status
Table 60: Smart Inhaler - Product Description

1.2 List of Figures
Figure 1: Inhalers - Pipeline Products by Stage of Development
Figure 2: Inhalers - Pipeline Products by Segment
Figure 3: Inhalers - Pipeline Products by Territory
Figure 4: Inhalers - Pipeline Products by Regulatory Path
Figure 5: Inhalers - Pipeline Products by Estimated Approval Date
Figure 6: Inhalers - Ongoing Clinical Trials

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Inhalers - Medical Devices Pipeline Assessment, 2019

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027